IFP Advisors Inc Purchases 6,393 Shares of Omega Healthcare Investors, Inc. $OHI

IFP Advisors Inc lifted its position in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 6.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 111,938 shares of the real estate investment trust's stock after acquiring an additional 6,393 shares during the quarter. IFP Advisors Inc's holdings in Omega Healthcare Investors were worth $4,103,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in OHI. Callan Family Office LLC purchased a new position in Omega Healthcare Investors in the second quarter valued at about $249,000. Columbus Macro LLC grew its stake in Omega Healthcare Investors by 11.0% in the second quarter. Columbus Macro LLC now owns 185,100 shares of the real estate investment trust's stock valued at $6,784,000 after purchasing an additional 18,274 shares during the last quarter. Hager Investment Management Services LLC grew its stake in Omega Healthcare Investors by 3.6% in the second quarter. Hager Investment Management Services LLC now owns 51,207 shares of the real estate investment trust's stock valued at $1,877,000 after purchasing an additional 1,799 shares during the last quarter. Cornerstone Enterprises LLC grew its stake in Omega Healthcare Investors by 37.5% in the second quarter. Cornerstone Enterprises LLC now owns 186,758 shares of the real estate investment trust's stock valued at $6,845,000 after purchasing an additional 50,928 shares during the last quarter. Finally, Maryland State Retirement & Pension System grew its stake in Omega Healthcare Investors by 10.7% in the second quarter. Maryland State Retirement & Pension System now owns 13,957 shares of the real estate investment trust's stock valued at $512,000 after purchasing an additional 1,352 shares during the last quarter. 65.25% of the stock is currently owned by institutional investors.

Omega Healthcare Investors Price Performance

Shares of OHI stock opened at $39.83 on Friday. Omega Healthcare Investors, Inc. has a fifty-two week low of $35.04 and a fifty-two week high of $44.42. The firm has a market capitalization of $11.75 billion, a price-to-earnings ratio of 24.59, a PEG ratio of 1.88 and a beta of 0.70. The company has a debt-to-equity ratio of 0.96, a quick ratio of 7.10 and a current ratio of 7.10. The stock's 50-day simple moving average is $41.57 and its 200-day simple moving average is $38.80.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, topping analysts' consensus estimates of $0.45 by $0.32. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The business had revenue of $235.60 million for the quarter, compared to analyst estimates of $248.49 million. During the same quarter in the previous year, the firm earned $0.71 earnings per share. The company's revenue was up 11.8% on a year-over-year basis. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. As a group, equities analysts forecast that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Monday, August 4th were issued a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, August 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.7%. Omega Healthcare Investors's payout ratio is 165.43%.

Insider Activity at Omega Healthcare Investors

In related news, Director Lisa Egbuonu-Davis sold 2,500 shares of Omega Healthcare Investors stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $40.16, for a total transaction of $100,400.00. Following the completion of the sale, the director owned 18,654 shares of the company's stock, valued at $749,144.64. The trade was a 11.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.50% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on OHI shares. Truist Financial lifted their target price on Omega Healthcare Investors from $39.00 to $44.00 and gave the company a "hold" rating in a research note on Wednesday, September 3rd. Scotiabank lifted their target price on Omega Healthcare Investors from $39.00 to $42.00 and gave the company a "sector perform" rating in a research note on Thursday, August 28th. Cantor Fitzgerald started coverage on Omega Healthcare Investors in a research note on Wednesday, October 1st. They issued an "overweight" rating and a $50.00 target price on the stock. Royal Bank Of Canada lifted their target price on Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a research note on Thursday, August 7th. Finally, Raymond James Financial restated an "outperform" rating on shares of Omega Healthcare Investors in a research note on Tuesday, September 2nd. Seven equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, Omega Healthcare Investors presently has an average rating of "Moderate Buy" and an average price target of $44.44.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.